【24h】

Hepatocyte Transplantation in Animal Models

机译:动物模型中的肝细胞移植

获取原文
获取原文并翻译 | 示例
           

摘要

More than 30 years after the first hepatocyte transplant to treat the Gunn rat, the animal model for Crigler-Najjar syndrome, there are still a number of impediments to hepatocyte transplantation. Numerous animal models are still used in work aimed at improving hepatocyte engraftment and/or long-term function. Although other cell sources, particularly hepatic and extrahepatic stem cells, are being explored, adult hepatocytes remain the cells of choice for the treatment of liver diseases by cell therapy. In recent years, diverse approaches have been developed in various animal models to enhance hepatocyte transduction and amplification in vitro and cell engraftment and functionality in vivo. They have led to significant progress in hepatocyte transplantation for the treatment of patients with metabolic diseases and for bridging patients with acute injury until their own livers regenerate. This review presents and considers the results of this work with a special emphasis on procedures that might be clinically applicable. Liver Transpl 15:7-14, 2009.
机译:首次肝细胞移植治疗了克格勒-纳杰哈尔综合征的动物模型Gunn大鼠后30多年,肝细胞移植仍然存在许多障碍。许多动物模型仍用于改善肝细胞植入和/或长期功能的工作中。尽管正在探索其他细胞来源,特别是肝和肝外干细胞,但成年肝细胞仍然是通过细胞疗法治疗肝病的首选细胞。近年来,已经在各种动物模型中开发了多种方法来增强体外肝细胞的转导和扩增以及体内细胞的植入和功能。它们在肝细胞移植方面取得了重大进展,用于治疗代谢性疾病和桥接急性损伤的患者,直到他们的肝脏再生为止。这篇综述介绍并考虑了这项工作的结果,并特别强调了可能在临床上适用的程序。肝运输15:7-14,2009。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号